Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.

NCT06320080 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
22
Enrollment
INDUSTRY
Sponsor class

Stopped This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.

Conditions

Interventions

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.